Herceptin cures breast cancer in half the time

Professor Helena Earl, who led the Cambridge researchers, said: “We are confident that this will mark the first steps towards a reduction in treatment duration for many women with HER2-positive breast cancer. Women with aggressive breast cancer can be effectively cured in half the time compared to current treatment, minimising harmful side effects, researchers have said.compared to current treatment, minimising harmful side effects, researchers have said. Read more: The Telegraph